Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD

Chest

Volumn 136, Issue 4, 2009, Pages 1047-1054

  Corhay, Jean Louis ^a   Henket, Monique ^a   Nguyen, Delphine ^a   Duysinx, Bernard ^a   Sele, Jocelyne ^a,b   Louis, Renaud ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; INTERLEUKIN 8; LEUKOTRIENE B4; FATTY ALCOHOL; GLYCOL;

ADULT; AGED; ARTICLE; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPIRED AIR; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; PRIORITY JOURNAL; SPUTUM; SUPERNATANT; BREATH ANALYSIS; CYTOLOGY; EXHALATION; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY;

BREATH TESTS; CHEMOTAXIS, LEUKOCYTE; EXHALATION; FATTY ALCOHOLS; GLYCOLS; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOTRIENE B4; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 70350094552     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2782     Document Type: Article

References (29)

1. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1304-1309 (Pubitemid 32506590)
2. Peleman RA, RytiläPH, Kips JC, et al. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999; 13:839-843 (Pubitemid 29234788)
3. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653 (Pubitemid 38787999)
4. O'Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004; 59:837-842 (Pubitemid 39389622)
5. 4. Chest 2003; 123:1240-1247
6. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534 (Pubitemid 126423950)
7. Traves SL, Culpitt SV, Russell RE, et al. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002; 57:590-595
8. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005; 356:22-34 (Pubitemid 40779884)
9. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J: 2005; 26:523-548 (Pubitemid 41264218)
10. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58:585-588
11. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58:294-298
12. 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127:1553-1559
13. Cunningham S, McColm JR, Ho LP, et al. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15:955-957 (Pubitemid 30321857)
14. Simpson JL, Wood LG, Gibson PG. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005; 35:1180-1185
15. Garey K, Neuhauser MM, Robbins RA, et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125:22-26 (Pubitemid 38114559)
16. Corhay J-L, Hemmelaers L, Henket M, et al. Granulocyte chemotactic activity in exhaled breath condensate of healthy subjects and patients with COPD. Chest 2007; 131:1672-1677 (Pubitemid 46981619)
17. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2006. Available at: http://www.goldcopd.com. Accessed August 30, 2009
18. Delvaux M, Henket M, Lau L, et al. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 2004; 59:111-115 (Pubitemid 38223480)
19. Thurlbeck WM. Pathology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:389-404
20. Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285 (Pubitemid 28489033)
21. Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51:1000-1004 (Pubitemid 26360175)
22. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151-155
23. Richman-Eisenstat JBY, Jorens PG, Hebert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264:L413-L418
24. Mikami M, Llewellyn-Jones CG, Bayley D, et al. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998; 157:723-728 (Pubitemid 28150679)
25. 4 and interleukin 8. Thorax 2002; 57:709-714
26. Yoshikawa T, Dent G, Ward J, et al. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:473-479 (Pubitemid 46354251)
27. 4 in exhaled breath condensate. Eur Respir J 2006; 28:1229-1235
28. Bayley DL, Abusriwil H, Ahmad A, et al. Validation of assays for inflammatory mediators in exhaled breath condensate. Eur Respir J 2008; 31:943-948
29. 4. Eur Respir J 2000; 15:274-280